The global annual ISPOR conference includes the international HEOR community of global leaders, policy makers, regulators, researchers, academics, payers, patients, and patient groups. This multi-stakeholder group is invested in using science and research to make better health care decisions. The diversity in work environments and international scope of attendance provide excellent networking opportunities and stimulating discussions and debate.
|Monday, May 16, 10:15 – 11:15 am|
W2 | SEE Sense: Tools for Conducting Structured Expert Elicitation to Support Healthcare Decision Making
Lumanity’s Dawn Lee leads the discussion and is joined by Lumanity’s James Horscroft and the University of York’s Laura Bojke and Dina Jankovic to conduct a live demonstration of resources developed to support structured expert elicitation (SEE) in healthcare decision making, using case studies as examples.
|Tuesday, May 17, 2022 10:15 – 11:15 am|
W15 | Conceptual Issues in the Valuation of Health in Children
Lumanity’s Simon McNamara leads the discussion and is joined by Pfizer’s Ernest Law, University of Melbourne’s Tessa Peasgood, and NICE’s Koonal Shah. The discussion will clarify key conceptual issues in the valuation of health in children through a participatory workshop, and so enable ISPOR delegates to develop their own views on how the health of children should be valued.
|Tuesday, May 17, 2022|
Poster Session 3 | View on ISPOR website
Budget Impact Analysis of Sentinel Prostate Test Versus Current Diagnostic Strategy for Men with Suspicion of Prostate Cancer in the US
Meng Y, Tenniswood M, Elsea D, Kowalski J
|Wednesday, May 18, 2022|
Poster Session 5 | View on ISPOR website
Comparative Efficacy of Osilodrostat Versus Pasireotide Subcutaneous and Pasireotide Long-Acting Release for the Treatment of Cushing’s Disease – A Patient-Level Data Indirect Treatment Comparison Using Propensity Score Weighting
Tyas E, Piacentini A, Hemstock M, Lilley C, Lebbink E, Matthijsse S, Schmidt F, Maman K